Your prescriber sets your actual dose, and compounded products can differ
In general, expression of ER is downregulated or lost in high grade breast tumors, but its relation to clinical outcome does not reach an agreed conclusion (212)
Cardiovascular safety DPP-4 inhibitors provide no benefits above the standard of care for people with established or high risk of atherosclerotic cardiovascular disease, heart failure or chronic kidney disease
Nevertheless, there is no solid evidence about their effectiveness and more extensive studies should be performed [19, 23]
54 In addition, elevated plasma nonesterified fatty acid (NEFA) levels impaired the insulin-induced increase in IRS-1-associated PI3K activity, but no defect in Akt phosphorylation was observed
That means there is no standard label, no standard tracking, and no clean path for quality checks